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Background: Parkinson’s disease is characterized by a continuous loss of neurons within the substantia nigra (SN)
leading to a depletion of dopamine. Within the adult SN as a non-neurogenic region, cells with mainly
oligodendrocytic precursor characteristics, expressing the neuro-glial antigen-2 (NG2) are continuously generated.
Proliferation of these cells is altered in animal models of Parkinson’s disease (PD). Exercise and environmental
enrichment re-increase proliferation of NG2+ cells in PD models, however, a possible mechanistic role of dopamine
for this increase is not completely understood. NG2+ cells can differentiate into oligodendrocytes but also into
microglia and neurons as observed in vitro suggesting a possible hint for endogenous regenerative capacity of the
SN. We investigated the role of dopamine in NG2-generation and differentiation in the adult SN stimulated by
physical activity and environmental enrichment.
Results: We used the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-model for dopamine depletion and
analysed newborn cells in the SN at different maturation stages and time points depending on voluntary physical
activity, enriched environment and levodopa-treatment. We describe an activity- induced increase of new
NG2-positive cells and also mature oligodendrocytes in the SN of healthy mice. Running and enriched environment
refused to stimulate NG2-generation and oligodendrogenesis in MPTP-mice, an effect which could be reversed by
pharmacological levodopa-induced rescue.
Conclusion: We suggest dopamine being a key regulator for activity-induced generation of NG2-cells and
oliogodendrocytes in the SN as a potentially relevant mechanism in endogenous nigral cellular plasticity.
Keywords: Physical activity, Environmental enrichment, Dopamine, NG2, Oligodendrocytes, Substantia nigraBackground
The hallmark of Parkinson’s disease (PD) is the degener-
ation of dopaminergic neurons in the substantia nigra (SN)
[1]. Although the adult brain bears the lifelong capacity to
generate neural precursor cells and neurons, regeneration
of nigral dopaminergic neurons remains controversially dis-
cussed [2-5]. In animal models of PD glial cells with fea-
tures of oligodendrocytic precursors such as the expression* Correspondence: barbara.steiner@charite.de
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reproduction in any medium, provided the orof the neuro-glial antigen 2 (NG2) are continuously gener-
ated in the adult SN [5,6]. Voluntary physical activity and
environmental enrichment robustly regulate proliferation
of NG2+ oligodendrocytic precursors in the SN [6]. We
previously showed a decreased nigral NG2+ cell prolifera-
tion following 6-hydroxydopamine (6-OHDA)-induced
dopamine depletion in rats. This effect was restored by
physical activity and environmental enrichment and corre-
lated with improved motor behavior [6]. If and how these
new cells could add to an endogenous restorative pool fol-
lowing neurodegeneration remains unclear. It is known,
that lack of dopamine leads to decreased generation ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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oligodendrocytes in PD brain has so far not been described
in detail. Few studies investigated orthotopic neural (mainly
glial) regeneration in the adult SN, the major origin of
dopaminergic pathways, but refused observing neurogen-
esis [2,3,5,11,12]. It is known, that activity induced prolif-
eration, differentiation and survival of glial cells is regulated
differentially from neuronal cells [13-15]. Especially mat-
uration of NG2+ cells is strongly influenced by physical
exercise and environmental enrichment but also by
pathological processes in various areas of the adult brain
[14-18].
We analysed newly generated nigral NG2+ cells, oligo-
dendrocytes and Nestin-GFP+ neural precursors over
time, depending on the presence of dopamine and
stimulation by physical activity and environmental en-
richment. Oligodendrocyte and NG2+ derived factors
have been postulated to play a neurotrophic/neuropro-
tective role for dopaminergic neurons [19,20]. On the
other hand, disturbances in nigral oligodendrogenesis
seem to be pathognomonic in PD brain [21,22]. As
dopamine is involved in activity-induced neuroprotec-
tion in PD brain [23-25], we analysed new nigral NG2+
cells and mature oligodendrocytes following 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP) lesion at vari-
ous time points combined with physical activity and
enriched environment. To differentiate between the
dopamine and activity effect on oligodendrocytic and
other neural precursors, we used mice expressing the
green fluorescent protein (GFP) under the promoter of
the neural precursor marker Nestin and quantified new-
born cells by incorporation of the proliferation marker
bromodeoxyuridine (BrdU). In vitro analyses were per-
formed to study the differentiation potential of precursor
isolated from the SN following MPTP-treatment. L-dopa
treatment was used to rescue a dopamine deficit in
MPTP treated mice.
Results
Increased numbers but reduced survival of new nigral
cells following levodopa-treatment of MPTP-mice
To analyse the effects of MPTP-treatment on generation
of newborn cells within the SNpc and SNpr, we quanti-
fied BrdU+ cells at various time points after MPTP treat-
ment. Three days after BrdU administration, we detected
an increase in BrdU+ cells in the SN of MPTP-treated
mice compared to saline-treated controls in both the
SNpc and the SNpr (Figure 1A-C; SNpc: one-way-
ANOVA: p<0001 F(7;31): 3.4; SNpr: one-way-ANOVA:
p<0.001 F(7;31): 30.6). At 10 and 28 days after BrdU, no
differences in the numbers of BrdU+ cells were detected
between MPTP-treated and control groups (Figure 1B,
C). Long term observations (70d after BrdU and after
MPTP), showed a significant decrease in the numbers ofBrdU+ cells in the MPTP-treated mice compared to con-
trols, indicating a reduced long-term survival of new-
born nigral cells in the SN (Figure 1B, C).
After 10 days of levodopa treatment, significant effects
of MPTP on the numbers of new nigral cells compared
to healthy controls were observed (two-way ANOVA
F(1;16): 14.6, p=0.002). The same held true for levodopa
treatment compared to saline in MPTP-mice (two-way
ANOVA F(1;16): 23.4, p<0.001; Figure 1D, E). The signifi-
cant interaction effect (two-way ANOVA F(1;16): 8.8,
p=0.009) indicates that healthy controls and parkinsonian
mice were affected differently by levodopa, as BrdU+ cell
numbers increased after levodopa treatment in MPTP-
mice but not in controls (p=0.001). Levodopa-treated
MPTP mice also showed an increase in nigral BrdU+
cells compared to MPTP-treated mice without substitu-
tion of levodopa (p=0.001).
Generation of nigral NG2+ cells is increased in
levodopa-treated MPTP-mice
At all evaluated time points numerous BrdU+ cells
expressed NG2. In the three- and ten day groups 46-
56% of BrdU-labelled cells of healthy animals were
NG2+. This percentage decreased over time to 13%
after 70 days (Figure 2A). In the acute phase, 3 days
after BrdU-injection MPTP led to an increase in the
absolute numbers NG2+/BrdU+ cells in the SN compared
to saline-treated controls (one-way ANOVA: p=0.005,
F(7;26):8.09). At all further time points MPTP had no effect
on the numbers of newborn NG2+ cells (Figure 2B, 3A).
We observed a significant interaction effect between
levodopa and MPTP on the amount of newly generated
NG2+ cells (2way ANOVA F(1;13) 5.6, p=0.034). Specific-
ally levodopa led to an increase of NG2+ cells in MPTP-
treated mice, but not in healthy animals (Figure 3B).
Nigral oligodendrogenesis is disturbed by MPTP but
remains unchanged by levodopa-rescue
NG2 is described as a marker for oligodendrocytic precur-
sor cells (OPCs) with also a potential to differentiate into
neurons or other non-neuronal cells in vitro ([19,26-29].
Since a decrease of nigral BrdU+ and NG2+ cells over time
was apparent in all groups we hypothesized that this could
be due to maturation into oligodendrocytes. Mature oligo-
dendrocytes were characterized by CNPase-expression.
Three days after BrdU-administration no BrdU+/CNPase+
cells were detected in any group (Figure 2C, 3C). Ten days
after BrdU, we found new CNPase+ oligodendrocytes in
the SN of both MPTP- and saline-treated mice without
differences in the numbers of these cells between groups
(one-way ANOVA: p=0.83, F(5;18):11.5; Figure 3C). An in-
crease in the numbers of BrdU+/CNPase+ cells over time
between 10 and 28 days was detectable in healthy, saline-
treated mice in parallel to the decrease of new NG2-
Figure 1 Histological analysis and quantification of the absolute numbers of BrdU+ cells in the substantia nigra pars reticulata (SNpr)
and compacta (SNpc) at different time points following BrdU and first saline or MPTP injection. Data are expressed as mean +/− S.E.M.
A: BrdU-positive cells in the SN of healthy control animals (control) versus MPTP-treated animals (MPTP). Representative coronal 40μm sections at
day 3 after BrdU administration and first saline (control) or MPTP injection are given. Scale bar 100μm. B: In short term groups (3 days) MPTP
induced a significant increase in the number of BrdU+ cells in the SNpr compared to saline-treated controls. In the 70 days-group MPTP caused a
significant decrease in the numbers of BrdU+ cells compared to saline-treated controls. *p < 0.05, **p < 0.001 versus corresponding control
(n= 5; LSD post hoc test). C: Only in short term groups (3 days) MPTP induced a significant increase in the number of BrdU+ cells compared to
saline-treated controls in the SNpc. **p < 0.001 versus corresponding control (n= 5). D: In the SNpr there was a significant interaction effect
between MPTP-treatment (MPTP versus control) and levodopa-treatment (L-Dopa versus saline), as levodopa treatment in addition to
MPTP-treatment (MPTP + L-Dopa) increased the number of BrdU+ cells compared to saline-treated controls (control, saline), MPTP and saline
treated mice (MPTP, saline) and levodopa-treated mice. *p < 0.05 versus other groups (n ≥ 5; LSD post hoc test). E: There were no effects of
levodopa-treatment or MPTP on the number of BrdU+ cells in the SNpc.
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maturation in the healthy SN (one-way ANOVA:
p=0.001, F(5;18):11.5; Figure 3C). In parallel, the percent-
age of CNPase+ cells among all BrdU+ cells in healthy
animals increased from 13% at 10 days to 29% at 28days and remained at that level at 70 days (26%;
Figure 2A). In MPTP treated mice however, there was
no difference in BrdU+/CNPase+ cells at 10 and 28 days
(one-way ANOVA: p=0.67, F(5;18): 11.5, Figure 3C) and
the percentage of CNPase+ cells among all BrdU+ cells
Figure 2 (See legend on next page.)
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Figure 2 Co-localization of BrdU-positive cells with different cell markers. A: Relative numbers of co-localization of NG2-positive cells with
BrdU+ cells (NG2+), CNPase- positive cells with BrdU+ cells (CNPase+) and unidentified BrdU+ cells (BrdU+) in saline treated, healthy controls
(left panel) and MPTP treated animals (right panel) at different time points. B-D: Overview of exemplary BrdU+ cells expressing characteristic cell
markers in the substantia nigra after 10 days. Left panel shows BrdU (red), central panel shows markers NG2 (blue), CNPase (blue), NesGFP (green),
right panel shows overlay. Scale bar 10μm.
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points (10, 28, 70 days post MPTP, Figure 2A). Moreover,
MPTP induced a significant decrease in the number of
BrdU+/CNPase+ cells compared to healthy controls after
28 days, with continuous decrease of new CNPase+ cells
at the 70 days time point (one-way ANOVA: p<0.001,
F(5;18):11.5, Figure 3C). We could not rescue this effect
by treatment with levodopa (Figure 3D).
No influence of dopamine-depletion and levodopa-
treatment on nestin-GFP-expressing neural precursor cells
To investigate if the dopaminergic influence also becomes
relevant in the stimulation of other neural precursor cell
populations in the SN, we quantified Nestin-GFP-
expressing cells over time. These cells represent a small
population of BrdU+ cells in the SN with decreasing cell
numbers over time from 8.4-11.6% on the third day to 1.5-
2% after 70 days (Figure 2D, 3E). In the 3 day groups
MPTP induced a significant transient increase in the num-
bers of Nestin-GFP+ newborn cells compared to controls
as a potential reactive cell response to toxicity. Thus, in the
10 day groups we did not detect any significant differences
in numbers of Nestin-GFP+/BrdU+ cells, this also held true
for 28 and 70 days (Figure 3E). Levodopa treatment did not
influence the numbers of new Nestin-GFP+ cells (two-way
ANOVA F(1;16) 0.27, p=0.61, Figure 3F).
The proliferative effect of physical activity and
environmental enrichment on nigral cells is suppressed
after MPTP-treatment
We have previously shown the effects of physical activity
(RUN) and environmental enrichment (ENR) on nigral
cell proliferation in adult rats [6]. In the present study
RUN and ENR increased the numbers of BrdU+ cells in
the SN of healthy mice at all evaluated timepoints
(Figure 4A). RUN and ENR had no effect on the numbers
of BrdU+ cells in the SN of MPTP-treated animals at any
time point, suggesting a role for dopamine in activity-
induced nigral cell proliferation (one way ANOVA: 3d:
p=0.9, p=0.84, 10d: p=0.87, p=0.46, 28d: p=0.92, p=0.38,
70d: p=0.08, p=0.05, F(23;80):19.22, Figure 4A).
Levodopa rescue re-induces nigral cell generation in
MPTP-treated mice
Assuming a key role for dopamine in activity-induced
cell proliferation in the SN, we next tested whether thelack of response to physiological stimulation by RUN and
ENR MPTP-treated animals could be reversed by admin-
istration of levodopa. MPTP-treated mice received levo-
dopa for 10 consecutive days. In these animals, there was
a significant main effect of levodopa treatment (three-
way ANOVA F(1;44) 93.8, p<0.001) and MPTP-treatment
(three-way ANOVA F(1;44) 12.63, p=0.001), a significant
interaction effect between levodopa-treatment and MPTP-
treatment (three-way ANOVA F(1;44) 72.1, p<0.001) and a
significant interaction effect between levodopa, physical
stimulation and MPTP (three-way ANOVA F(2;44) 7.88,
p=0.001) on the numbers of BrdU+ cells in the SN
(Figure 4B). Thus, the effects of physiological stimulation
on the numbers of BrdU+ nigral cells could be restored
by levodopa. Administration of levodopa to saline-treated
controls had no effect on nigral cell proliferation (two-way
ANOVA: p=0.0281 F(1;22) 1.22; Figure 4B).Generation of nigral NG2+ cells in MPTP-mice induced by
RUN and ENR depends on the presence of dopamine
In the next step we analysed the role of activity and levo-
dopa on the numbers of new NG2+ cells in the SN. Except
for the short-term exercise group (one-way ANOVA:
p=0.0134, F(29;98): 18.4) and the 70 days exercise group
(one-way ANOVA: p=0.0054 F(29;98): 18.4) all healthy con-
trols exposed to RUN and ENR showed an increase in the
numbers of BrdU+/NG2+ cells in the SN compared to con-
trols under standard housing conditions (one-way ANOVA:
3d: p=0.04, 10d: p=0.036, p<0.001, 28d: p<0.001, 70d:
p=0.007F(29;98): 18.4, Figure 4C).
In MPTP-treated mice, ENR and RUN increased the
numbers of newborn NG2+ cells only in the short term
group (one-way ANOVA: p<0.001, F(29;98): 18.4). These dif-
ferences were no longer apparent at later time points
(Figure 4D). When MPTP-treated mice received levodopa
for 10 days, there was a significant main effect for levodopa
(three-way ANOVA: F(1;41) 34.65, p<0.001), a significant
interaction effect between levodopa-treatment and MPTP-
treatment (three-way ANOVA: F(1;41) 59.1, p<0.001) and a
significant interaction effect between levodopa, physical
stimulation and MPTP (three way ANOVA_ F(2;21) 6.13,
p=0.005). This indicates that the effect of physiological
stimulation on BrdU+/NG2+ nigral cells in MPTP mice
depends on levodopa treatment. In controls, levodopa treat-
ment had no effects (two-way ANOVA: F(1;20) 2.29,
p=0.146; Figure 4E).
Figure 3 Histological analysis and quantification of the absolute numbers of co-localization of BrdU-positive cells with NG2+ cells,
CNPase+ mature oligodendrocytes and nestin-GFP+ neural precursors in the SN. Effects of 10 days of levodopa treatment. A: In short term
groups MPTP induced a significant increase in the number of co-labeled BrdU+ and NG2+ in the SN compared to saline-treated controls. At later
time points this effect was not detectable. The numbers of co-labeled BrdU+ and NG2+ cells decreased over time in controls and MPTP groups.
B: At day 10 the number of co-labeled BrdU+ and NG2+ cells was significantly increased in MPTP mice that were treated with levodopa. C: After
3 days no newborn mature oligodendrocytes were detectable. In 28- and 70 day groups MPTP induced a decrease in co-labeled BrdU+ and
CNPase+ cells compared to saline treated controls where an increase in CNPase+ cells was observed between 10 and 28 days. D: At day 10 the
number of BrdU+-labeled mature oligodendrocytes was not influenced by MPTP or levodopa. There was no significant interaction between
levodopa treatment and MPTP-treatment. E: In short term groups MPTP induced a significant increase in the number of BrdU+ neural precursors
(Nes-GFP-positive, Nes-GFP+) in the SN compared to saline-treated controls. In later groups no such effect was detectable. The number of
newborn NesGFP+ cells decreased over time in MPTP groups. F: At day 10 the number of BrdU+ neural precursors was not influenced by MPTP
or levodopa. There was no significant interaction between levodopa treatment and MPTP-treatment. *p < 0.05, **p < 0.001 versus corresponding
controls, ┌*┐p < 0.05, ┌**┐p < 0.001 versus other groups (n ≥ 5).
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affected by physiological stimuli or levodopa
The numbers of newly generated CNPase+/BrdU+ cells
were not changed by physical activity in any groups.
In controls after 28 days of exposure to an enrichedenvironment a transient increase in new CNPase+ cells
could be detected but the differences to the standard
housing conditions were not significant over time
(one-way ANOVA: 10d: p=0.04, p=0.99, 28d: p=0.62,
p=0.18, 70d: p=0.5, p=0.32, F(23;73): 6.7). In MPTP mice
Figure 4 Effect of physiological stimulation on absolute numbers of BrdU+ cells and doublelabelled BrdU+/NG2+ cells in the SN. A: In
healthy controls RUN and ENR induced a significant increase in the number of BrdU+ cells in the SNpr compared to STAN at all time points. RUN
and ENR had no effect in MPTP treated mice at any time point. In short term groups MPTP induced a significant increase in the number of
newborn cells in the SN compared to saline-treated controls, independently of physiological stimulation. B: At day 10 the number of BrdU+ cells
was significantly influenced when MPTP-treated mice additionally received levodopa (p<0.001). There was a significant interaction effect between
the three main factors (p=0.001). Specifically, levodopa strengthened the effects of physiological stimulation (RUN and ENR) on BrdU+ cells in
MPTP groups compared to controls without levodopa. *p < 0.05, **p < 0.001 versus corresponding STAN. C: In healthy controls ENR induced a
significant increase in the number of BrdU+/ NG2+ cells in the SN compared to STAN at all time points. RUN induced a significant increase in the
number of NG2+ cells in the SN compared to STAN at 10 and 28 days. RUN and ENR significantly increased the number of BrdU+/ NG2+ cells in
MPTP treated mice only at the 3d time point. In short term groups MPTP induced a significant increase in the number of BrdU+ /NG2- positive
cells in the SN compared to saline-treated controls, independently of physiological stimulation. D: At day 10 the number of NG2+ and BrdU+
cells was significantly influenced by levodopa and physiological stimulation. The significant interaction effect between MPTP, levodopa and
physiological stimulation shows that levodopa strengthened the effects of physiological stimulation (RUN and ENR) on BrdU+ cells in MPTP
groups in contrast to controls without levoopa. *p < 0.05, **p < 0.001 versus corresponding STAN.
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stimulation. We neither detected a main effect of
physiological stimulation (two-way ANOVA: F(2;18)
0.45, p=0.64) nor an interaction effect between levo-
dopa and physiological stimulation on the numbers of
CNPase+/BrdU+ cells (two-way ANOVA: F(2;18) 1.4,
p=0.27). Levodopa had no effect on CNPase+/BrdU+
cells (two-way ANOVA: F(1;18) 3.1, p=0.094).The in vivo increase of Nestin-GFP+ cells is also reflected
in neurosphere-forming cells in vitro
To investigate whether the short term increase of nes-
tin-GFP+ cells within the SN after 3 days post MPTP
in vivo translates into an appearance or increase of
neurosphere-forming NPCs in vitro as a potential re-
storative capacity of this cell population, we quantita-
tively analysed the number of isolable NPCs within the
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duced by Lefkovits and optimized for the selection of
multipotent adult NPCs [3,30,31]. Neurospheres with
identical morphology could be detected after 7–10
days in vitro independently of the brain’s region of ori-
gin. Quantitative colony forming assays revealed an ex-
treme low occurrence of neurosphere-forming cells
within the SN (approx. 1 colony-forming cells out of
10,000 isolated cells) with no differences between
MPTP-treated and control animals in any brain region
(Figure 5). NPCs of the SVZ of both controls and
MPTP-treated animals did not show any differences in
morphology, nestin-GFP expression (Figure 5) or NPC
marker expression (Olig2, Sox2, NG2; data not shown).
Of note, proliferation-frequencies of isolated NPCs
from the SN were so rare and long-term culture over
two weeks and subsequent further characterizations
were not possible.No newborn neurons, astrocytes or endothelial cells were
found in the SN at any time point
We analysed the phenotypic distribution of newly gener-
ated BrdU+ cells in the SN at all time points following
MPTP treatment. Laser confocal microscopy permitted
to evaluate the colocalization and quantification of pro-
liferated cells with immature and mature neuronal, glial,
and endothelial markers (Nestin-GFP, DCX, NeuN, TH,
S100ß, GFAP, NG2, CNPase, Iba1, vWF, CD31). No co-
expression of immature (DCX) or mature neuronal mar-
kers (NeuN) with BrdU was found at any time point. No
proliferated astrocytes (GFAP) or endothelia (anti-vWF)
were located in the SN either.MPTP induced decrease in TH-immunoreactivity in the
SNpc is not reversible by levodopa treatment
To assess the effect of MPTP treatment on dopamine
depletion in the SN we quantified TH-expressing dopa-
minergic neurons in the SN at 3, 10, 28 and 70 days
after the first MPTP injection (see Figure 6 for experi-
mental design). MPTP-treated animals showed a signifi-
cant decrease of TH-expressing cell counts compared
to saline-treated controls at all analysed time points
(Figure 7; one-way ANOVA: p<0.001 F(9;42): 19.8). After
70 days, TH-immunoreactive cell numbers in MPTP
treated mice were increased compared to the cell num-
bers in MPTP mice after 10 days (one-way ANOVA:
p=0.023; F(9;42): 19.8). Ten days of levodopa treatment
had no effect on the TH-expression, neither in MPTP
treated animals, nor in controls (Figure 7; one-way-
ANOVA: p=0.671, p=0.502 ANOVA, F(9;42): 19.8). Phys-
ical activity (RUN) and environmental enrichment
(ENR) had no effect on TH-positive cell numbers at
any time (data not shown).Discussion
Although the adult SN lacks the capacity to generate
dopaminergic neurons, generation of non-neuronal cells
has been robustly shown in the adult nigra [5,6]. The
origin and functional role of these cells are still under
debate [3]. These cells mainly express the neuro-glial
antigen NG2, which marks oligodendrocytic precursors
and also a number of cells with the potential to differen-
tiate into neurons or microglia [19,26,27,29]. The main
hallmark of PD is dopaminergic neurodegeneration in
the SN and the goal for potential restorative therapies in
the future might be the replacement of dying tissue by
potential neural precursors. We asked, if the generation
and differentiation of nigral NG2+ cells depends on
dopamine and if and how physical activity and environ-
mental enrichment would influence these cell popula-
tions and their potential differentiation. In the first step
we quantified all BrdU+ cells in the SNpc and SNpr. As
we found that in both areas the numbers of BrdU+ cells
were equally significantly increased following MPTP but
the absolute numbers of these cells were very low, we
did not further differentiate between SNpc and SNpr in
the phenotypic analyses of BrdU+ cells. The small num-
bers of BrdU+ cells in the SN might be due to the usage
of only one proliferation marker and its systemic appli-
cation. Other groups reported the local, intrastrial appli-
cation of BrdU and consecutively higher numbers of
labelled cells [4]. However, intrastriatal application
requires a surgical intervention which per se already
induces changes in the local microenvironment and
might be responsible for changes in the numbers of
newborn cells. Thus, the de facto number of BrdU+ cells
in the SN might be higher than detected by our meth-
ods. The analyses of all BrdU+ cells in the SN over time
showed an initial significant increase in the numbers of
BrdU+ cells in MPTP-treated mice compared to con-
trols. Within a few days the numbers decrease signifi-
cantly indicating an initial transitory reactive cell
proliferation following the lesion. This hypothesis is sup-
ported with the finding, that a large number of these
cells were microglia at this time-point and the percent-
age of microglial cells of all BrdU+ cells did not play a
role at any later time point or treatment. One could as-
sume, that after an initial activation these cells either die
or migrate away from the lesion site. This migration-
hypothesis at the early time point in MPTP-mice would
also support the finding, that in healthy control animals
the numbers of BrdU+ cells remain stable over a long
period of time (70 days in our study) without a significant
effect of e.g. aging on the numbers of BrdU+ cells in
the SN.
Regarding the phenotypic distribution we found a
significant number of the newborn nigral cells co-
expressing NG2. These cells were robustly regulated by
Figure 5 In vitro characterization of NPCs derived from microdissected periventricular regions throughout the brain. A: Schematic brain
images showing the regions which were microdissected for NPC culture. B: Limiting dilution assay for primary neurospheres from different
regions of control mice are shown (n=3). C: Limiting dilution assay for primary neurospheres from different regions of MPTP-treated mice are
shown (n=3-6). Data are shown as mean±SEM, dotted lines represent 95% confidence interval (95%CI). The intercept of log (37% negative wells)
gave the neurosphere-forming frequency. D-E: Representative neurospheres of NesGFP mice are depicted after one week of expansion of control
(D) and MPTP-treated animals (E). Scale bar, 100 μm.
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Figure 6 Schematic representation of the experimental design.
Figure 7 Histological analysis and quantification of MPTP-induced degeneration of Tyrosinhydroxylase-positive (TH+) dopaminergic
neurons in the substantia nigra (SN). A: TH-expressing dopaminergic neurons in the SN detected by immunohistochemistry. Representative coronal
40μm sections at day 10 after saline (control) or MPTP injection (MPTP) are given. Scale bar 100μm. B: MPTP-treatment (MPTP) led to a significant decrease
in the numbers of TH+ dopaminergic neurons in the SN at all time points compared to controls (control). In MPTP-treated animals there was a recovery in
the numbers of TH+ neurons after 70 days compared to 10 days. 10 days of levodopa-treatment had no effect on MPTP- treated groups (L-Dopa MPTP) or
healthy controls (L-Dopa control). *p < 0.05, **p < 0.001 versus corresponding control (values from LSD post-hoc tests).
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http://www.biomedcentral.com/1471-2202/13/132physiological stimuli in healthy animals as expected from
previous work [6,14,15]. In contrast to studies in the 6-
OHDA PD rat model, we did not detect an influence of
activity on the numbers of NG2+ cells of parkinsonian
MPTP-treated mice. This might be mainly explained by
species and animal model differences. Not till additional
treatment with levodopa as dopamine rescue, nigral
NG2+ cell proliferation in mice with access to physical
activity or environmental enrichment was significantly
enhanced. These results suggest a function for dopa-
mine in activity-induced NG2+ cell generation. If these
new cells could in the end indeed play a role in neur-
onal restoration following dopaminergic neurodegen-
eration remains to be clarified, but their reactive
proliferation following MPTP and their vulnerability to
physiological stimuli and dopamine suggests a potential
function role in the dopamine-depleted brain.
Therefore, in the next step, we were interested if activity
had also a dopamine-dependent effect on long-term mat-
uration of NG2+ cells. The majority of the NG2+ cells in
the adult brain in vivo are oligodendrocytic precursors
[32,33], but NG2+ cells in the SN were also described to
maturate into microglia or in vitro into neurons and se-
crete neurotrophic factors as a potential endogenous
neuroprotective mechanism following neurodegeneration
[19,29,34]. The numbers of NG2+ cells in our study
decreased significantly over time. This decline implicates
a physiological differentiation process of NG2+ cells into
mature oligodendrocytes or other resident cell types in
the healthy SN. We thus quantified the numbers of
BrdU+ nigral oligodendrocytes by CNPase-expression
over time depending on MPTP-treatment and physio-
logical stimulation. In the short-term MPTP- and
saline-treated groups, no CNPase+ cells were detected
indicating the appearance of mature cell populations
rather at later time points. The first BrdU+/CNPase+
cells in the SN were detected 10 days after MPTP or
saline in both groups supporting the hypothesis of an
ongoing maturation process. In controls the numbers
of new CNPase+ cells increased over time in line with
a continuous decrease of NG2+ cell numbers. In con-
trast, MPTP-treated animals showed unchanged num-
bers of new CNPase+ cells in the SN, despite a
continuous decrease of NG2+ cells as a possibly sign
of a disturbed oligodendrocyte maturation process in
the SN following dopamine depletion in line with pre-
vious studies showing disturbances in oligodendrocytic
homeostasis following MPTP [21]. Another reason for
the decrease of NG2+ cells in MPTP mice and a lack
of increase of CNPase+ cells could be the maturation
of NG2+ cells in other neural cell types, but also
changes due to the aging brain between the earliest
and latest time points of our investigations. However, in
our model we did not observe any BrdU+ cell populationincreasing over time associated with the NG2+ cell
decrease.
The numbers of CNPase+ oligodendrocytes were not
altered by physiological stimulation or levodopa rescue
in any group and at any time point. As activity robustly
increases functionally relevant neurogenesis in neuro-
genic regions of the healthy brain [35,36], our data add
somewhat to the differentiation between neurogenic and
non-neurogenic regions and also show a different regu-
lation of nigral cells following physiological stimuli and
pharmacological treatment in line with comparable data
from the dentate gyrus [13]. In the SN activity regulated
cellular plasticity might occur on precursor cell level,
however the stimulus is not sufficient to induce or en-
hance the further maturation process of these cells. This
might be of interest in the context of a suggested neuro-
protective role for oligodendrocytes in the lesioned SN
most likely by protective factor secretion [37].
The maturation of NG2+ cells into microglia with neu-
roprotective capacities has been discussed recently [19].
Apart from a reactive general glia proliferation 3 days
after MPTP, we did not detect any significant changes of
Iba1-positive microglia or other glial cells in any group
at any time point in this present study. To address if
other neural precursors are generated in the SN in a
dopamine or activity dependent manner, we applied
MPTP to transgenic Nestin-GFP mice and visualised
new neural precursors in vivo [38,39]. No relevant in-
crease in the numbers of new Nestin-GFP cells was de-
tectable at any time point and treatment paradigm. This
is in agreement with the quantitative colony-forming
assay results showing no increase of isolatable NPCs fol-
lowing MPTP treatment for 3 days. The acute and tran-
sient increase of Nestin-GFP-cells and Iba-1 positive
microglia 3 days after MPTP possibly reflects an unspe-
cific reactive post-toxic proliferation [40-42].
After a primary reduction of TH-immunoreactivity, the
numbers of immunohistochemically detectable TH+ cells
in the MPTP-treated mice increased significantly over
time [43,44]. The mechanisms underlying this transient
degeneration remain widely unclear. No BrdU+/TH+
neurons have been detected in our study at any time.
Thus, the recovery of nigral neurons detected by TH
after MPTP administration might be due to a down-
regulation of TH-expression on neuronal cells in the SN
by MPTP followed by a re-expression of TH over time,
rather than by de facto degeneration of the neurons or
reactive proliferation of new dopaminergic neurons.
Both, physiological stimuli and levodopa rescue had no
effect on TH-expression in the SN at any time point.
One recent report showed forced treadmill-exercise
induced increase of the numbers of TH+ neurons in the
mouse SN [45]. On the other hand, exercise-induced
neuroprotection, but no neurogenesis in the SN was
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though one study reported neuronal generation in the
SN following MPTP [4], the majority of the studies
are in line with our findings of cell proliferation but
not neo-neurogenesis in the SN [2,5,6].
Taken together, the activity-induced generation of
NG2+ precursor cells in the SN critically depends on the
presence of dopamine. Based on this data, additional
studies will investigate the possible neuro-restorative
role of NG2+ nigral cells in PD-brain in dependence of
dopamine.
Conclusions
Physical activity and enriched environment induce gen-
eration of newborn cells in the adult mouse SN. The
majority of these cells are oligodendrocytic precursors
expressing NG2. In the MPTP-model for dopamine de-
pletion the effects of physiological stimuli are suppressed
and can be re-activated by levodopa. As NG2+ cells have
been reported to bear neuroprotective and neuroregen-
erative capacities in the adult, microenvironmental
changes in the SN following activity as a potential future
therapeutic strategy in PD should be analysed in future
studies based on the present findings.
Methods
Animals and housing
All animal experiments were institutionally approved
and authorized by the Ethical Committee for Health and
Social Care (“Landesamt für Gesundheit und Soziales”)
Berlin, Germany. Eight to twelve weeks old female trans-
genic mice, expressing green fluorescent protein under
the promoter of nestin on the genetic background of
C57Bl6 mice without any CNS or peripheral pathological
phenotype, were randomly assigned to groups of mini-
mum n=5 animals and kept at three different housing
conditions with a light/dark cycle of 12 hours and free
access to food and water [39]. The housing models con-
sisted of 1. standard housing (‘STAN’) conditions with
two mice per cage, 2. cages with voluntary access to a
running wheel (‘RUN’) with 2 mice per cage, 3. housing
in an ‘enriched environment’ (‘ENR’), with at least 5 mice
kept in a cage, 74 x 74 cm, containing changing food
locations, obstacles, places to hide, toys, allowing a




Sigma-Aldrich) was dissolved in 0.9% NaCl. Half of the
mice received 3 intraperitoneal injections of MPTP
(20mg/kg body weight) on three consecutive days. Con-
trols were treated with 0.9% NaCl for the same time
period (Figure 6).BrdU injection
Bromodeoxyuridine (BrdU, Sigma-Aldrich) was dissolved
in 0.9% NaCl and filtered. All mice received one intra-
peritoneal injection of BrdU (50mg/kg body weight) at
the first day of MPTP-injection (Figure 6).
Levodopa treatment
In order to investigate the effect of dopamine substitu-
tion in MPTP-treated animals, these mice received daily
doses of levodopa + benserazide (L-Dopa, 20mg/kg +
5mg/kg, Ferak Berlin + Sigma- Aldrich) for 10 days
starting on day 1 of MPTP or NaCl treatment, respect-
ively. Control mice received 0.9% NaCl under the same
conditions (Figure 6).
Perfusion and tissue preparation
Mice were deeply anesthetized with an overdose of keta-
mine and killed by transcardial perfusion with 4% paraf-
ormaldehyde (PFA) at different time points (day 3, 10,
28 and 70 post MPTP injection). Brains were removed
and fixed overnight in PFA at 4°C and then transferred
in 20% sucrose for dehydration. Brains were frozen in li-
quid nitrogen and cut to 40 μm coronal sections using a
cryostat (Cryocut 1800, Reichert-Jung) and then stored
in cryoprotectant at −20°C until histological analysis.
Immunohistochemistry
For BrdU staining, DNA was denatured in 2N HCL for
30 min at 37°C. Sections were treated with 0.6% H2O2 to
block endogenous tissue peroxidases. Hereafter sections
were washed and incubated with 2N HCL for 30 min at
37°C and rinsed in borate buffer and extensively washed
with Tris-buffered saline (TBS). Sections were incubated
with the primary antibodies (anti-BrdU, rat, 1:500, Bio-
zol; anti-TH, mouse 1:10 000, Sigma- Aldrich) overnight
at 4°C, rinsed in TBS and TBS plus and incubated with
the biotinylated secondary antibodies (anti-rat, 1:500,
Dianova; anti-mouse, 1:1000, Vector Laboratories) for
2 hours at room temperature. ABC reagent (Vectastain
Elite, Vector Laboratories) was applied for 1h at con-
centration of 9μl/ml. Diaminobenzidine (DAB, Sigma-
Aldrich) was used as a chromogen at a concentration
of 0.025mg/ml in TBS with 0.01% H2O2 and 0.04%
nickel-II-chloride.
Immunofluorescence
One-in-six series of nigral sections were triple labelled
for immunofluorescence. Sections were incubated with
the primary antibodies for 24h at 4°C, washed with TBS
and TBS plus and incubated with the secondary anti-
bodies for 4h at room temperature. Sections were then
washed, mounted on slides and coverslipped in polyvinyl
alcohol diazabicyclo-octane (PVA-DABCO, Sigma-
Aldrich) as anti- fading agent. The primary antibodies
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(rat, 1:500, Biozol), anti-TH (mouse, 1:10,000, Sigma-
Aldrich), anti-GFP (goat, 1:1000, APC Biermann Acris;
rabbit 1:200, Abcam), anti-Iba1 (rabbit, 1:1000, Wako),
anti- NG2 (rabbit, 1:200, Chemicon International), anti-
CNPase (rabbit, 1:1000, Abcam), anti- GFAP (guinea pig,
1:500, Advanced ImmunoChemistry), anti-Doublecortin
(goat, 1:200, Santa Cruz Biotechnology), anti-S100-beta
(mouse, 1:1000, Sigma-Aldrich), anti- activated Caspase3
( rabbit 1:150, Abcam), anti-von Willebrand Factor (anti-
vWF, rabbit, 1:250, Abcam). Secondary antibodies used
were: anti-rat Rhodamine X, anti-rabbit FITC, anti-rabbit
Cy5, anti-mouse Cy5, anti-guinea pig Cy5, anti-mouse
Dylight 405 (all 1:250, Dianova), anti-goat FITC (1:100,
Dianova), anti-goat Cy5 (1:500, Dianova).
Quantification and imaging
One in six sections (240 μm apart) of each brain of all
DAB stained animals was counted for BrdU- and TH-
positive cells throughout the substantia nigra both, the
pars compacta and pars reticulata (SN) bilaterally using a
Leica DM RXE microscope. The boundaries of the SN
were determined with reference to internal anatomic
landmarks using a mouse atlas (The Mouse Brain in
Stereotaxic Coordinates, Paxinos 2007) The substantia
nigra pars compacta and pars reticulata were delineated
at 10x magnification with reference to internal anatomic
landmarks. Tyrosine hydroxylase immunostaining was
used to approximate the border between the compacta
and reticulata area. The SN was outlined in every section
using the 10x objective. Actual counting was done using
the 40x objective. Resulting numbers were then multi-
plied by six in order to estimate the total number of
stained cells per SN. For immunofluorescence, all BrdU-
positive cells in the SN (minimum 18 cells) were ana-
lyzed for co-expression of glial, neuronal or vascular
markers using a confocal laser scanning microscope
(Leica DM 2500) under a 40x- or 63x objective. Absolute
numbers and ratios of double- or triple-labelled cells ver-
sus BrdU-positive cells are given. All images were taken
in sequential scanning mode and further processed in
Adobe Photoshop 7.0. Only general contrast adaptations
were made and figures were not otherwise manipulated.
Exemplary and representative images are presented.
Statistical analysis
All cell numbers are given as mean with standard errors
of the mean (S.E.M). All numerical analysis were per-
formed using SPSS 19. For comparisons one-, two-, and
three-way ANOVA was performed, followed by LSD post
hoc test when appropriate. In one-way ANOVA the factor
was ‘groups’, in two-way ANOVA the factors were MPTP
treatment (control vs MPTP) and L-dopa treatment (sa-
line vs levodopa) and in three-way ANOVA the factorswere MPTP treatment (control vs MPTP), L-dopa treat-
ment (saline vs levodopa) and physiological stimulation
(STAN vs RUN vs ENR). Differences were considered sta-
tistically significant at p<0.05.Neurosphere cultures
Mice were killed by cervical dislocation, their brains
removed and placed in ice-cold Hank’s balanced salt solu-
tion (HBSS) supplemented with 1% penicillin/strepomycin
and 1% glucose (all from Gibco, Tulsa, OK). Whole brains
were cut into coronal sections of approximately 500 μm
and the SN (defined as remaining tissue of the midbrain/
hindbrain region after removal of cerebellum and ven-
tricular zones of third ventricle, Aq, fourth ventricle), as
well as the periventricular region of the lateral ventricle
(LV, lateral wall) was then aseptically prepared. Expansion
of neurospheres was carried out for a maximum of 2 weeks
before further characterization [31]. Limiting dilution
experiments were done as described by Bull and Bartlett
[47]. In brief, primary cells were plated at reducing dens-
ities in 96-well plates (BD Biosciences, Australia) with
200 μl per well in NeurobasalW medium supplemented
with 1% glutamate, 2% B27 and 1% penicillin/strepomycin
containing 20ng/ml EGF (epidermal growth factor) and
FGF-2 (fibroblast growth factor 2). Cell suspensions were
diluted by serial 1:2 dilutions and cells were plated at 5 to
20,000 cells per well. After 7 days in vitro, the fraction of
wells negative for neurosphere formation was quantified.
These data were then log transformed passing through
zero fitted to the data (including the 95% confidence inter-
vals (95%CIs) using the Origin 5.0 software. The intercept
of log (37%) gave the frequency of cells capable of prolifer-
ating to form a neurosphere [3,30,31].Authors’ contribution
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